ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Extracorporeal circulation

May 23, 2018
Kawatsu and colleagues performed a retrospective analysis of preoperative characteristics and laboratory data for patients who did and did not exhibit heparin resistance (n = 25 and n = 464, respectively) prior to establishment of cardiopulmonary bypass for a cardiovascular operation.
May 9, 2018
The authors have used a number of novel kidney related biomarkers to improve the identification of patients with acute kidney injury (AKI) and its likely progression. This is an important issue in cardiac surgery, as the outcomes after significant kidney injury can be quite devastating.
May 8, 2018
This Three-Minute Review includes illustrations and flow charts to help simplify recalling the essential concepts and criteria of cardiopulmonary bypass.
May 3, 2018
Kyriakos Anastasiadis of the Aristotle University of Thessaloniki in Greece discusses the advances, definition, and benefits of minimally invasive extracorporeal circulation.
May 3, 2018
The latest on portable venovenous ECMO in a cohort in which half of the subjects died after a resource-intensive treatment. The results of the relevant EOLIA trial are keenly awaited.
May 3, 2018
A somewhat delayed publication of a 2016 paper that discusses important trends in cardiac transplanation in the light of increasing use of ECMO.
March 27, 2018
A brief readable editorial on a retrospective analysis of the costs of coronary artery bypass grafting in Virginia, USA, which suggests the value of enhanced recovery in coronopathy.
March 19, 2018
Common carotid artery cannulation can provide antegrade blood flow to the whole body during cardiopulmonary bypass, as well as maintain cerebral perfusion even at the time of arch exclusion or repair.
March 12, 2018
An interesting two-year report from the MOMENTUM 3 randomized controlled trial comparison of HeartMate 3 and II, the analysis performed by Abbott. Although stroke and reoperation were clearly lower with the latest technology, reflected in the lower LDH measurements, there was bafflingly no improvement in survival.  
February 21, 2018
A well-written, brief, pessimistic editorial on the loss of surgeon autonomy in innovation.

Pages